Your browser doesn't support javascript.
loading
Development of a Thalassemia International Prognostic Scoring System (TIPSS).
Vitrano, Angela; Musallam, Khaled M; Meloni, Antonella; Karimi, Mehran; Daar, Shahina; Ricchi, Paolo; Costantini, Silvia; Vlachaki, Efthymia; Di Marco, Vito; El-Beshlawy, Amal; Hajipour, Mahmoud; Ansari, Saqib Hussain; Filosa, Aldo; Ceci, Adriana; Singer, Sylvia Titi; Naserullah, Zaki A; Pepe, Alessia; Cademartiri, Filippo; Pollina, Sebastiano Addario; Scondotto, Salvatore; Dardanoni, Gabriella; Bonifazi, Fedele; Sankaran, Vijay G; Vichinsky, Elliott; Taher, Ali T; Maggio, Aurelio.
Afiliación
  • Vitrano A; Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy.
  • Musallam KM; Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
  • Meloni A; Department of Radiology, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy.
  • Karimi M; Haematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Daar S; Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Oman; Wallenberg Research Centre, Stellenbosch Institute for Advanced Study, Stellenbosch University, Stellenbosch, South Africa.
  • Ricchi P; Rare Blood Cell Disease Unit, "Cardarelli" Hospital, Naples, Italy.
  • Costantini S; Rare Blood Cell Disease Unit, "Cardarelli" Hospital, Naples, Italy.
  • Vlachaki E; Thalassaemia Unit, Ippokratio University Hospital, Thessaloniki, Greece.
  • Di Marco V; Sezione di Gastroenterologia e Epatologia, Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, Italy.
  • El-Beshlawy A; Department of Pediatric Haematology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Hajipour M; Pediatric Gastroenterology, Hepatology and Nutrition Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ansari SH; Children's Hospital Karachi (CHK), Karachi, Pakistan.
  • Filosa A; Rare Blood Cell Disease Unit, "Cardarelli" Hospital, Naples, Italy.
  • Ceci A; Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Valenzano (BA), Italy.
  • Singer ST; Division of Hematology-Oncology, Department of Pediatrics, University of California San Francisco, UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA.
  • Naserullah ZA; Dammam Maternity and Child Hospital, Dammam, Saudi Arabia.
  • Pepe A; Institute of Radiology, Department of Medicine, University of Padua, Italy.
  • Cademartiri F; Department of Radiology, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy.
  • Pollina SA; D.A.S.O.E, Regione Siciliana, Palermo, Italy.
  • Scondotto S; D.A.S.O.E, Regione Siciliana, Palermo, Italy.
  • Dardanoni G; D.A.S.O.E, Regione Siciliana, Palermo, Italy.
  • Bonifazi F; Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Valenzano (BA), Italy.
  • Sankaran VG; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Harvard Stem Cell Institute, Cambridge, MA, USA.
  • Vichinsky E; Division of Hematology-Oncology, Department of Pediatrics, University of California San Francisco, UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA.
  • Taher AT; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Maggio A; Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy. Electronic address: md.amaggio@gmail.com.
Blood Cells Mol Dis ; 99: 102710, 2023 03.
Article en En | MEDLINE | ID: mdl-36463683
ABSTRACT
A prognostic scoring system that can differentiate ß-thalassemia patients based on mortality risk is lacking. We analysed data from 3145 ß-thalassemia patients followed through a retrospective cohort design for the outcome of death. An a priori list of prognostic variables was collected. ß Coefficients from a multivariate cox regression model were used from a development dataset (n = 2516) to construct a formula for a Thalassemia International Prognostic Scoring System (TIPSS) which was subsequently applied to a validation dataset (n = 629). The median duration of observation was 10.0 years. The TIPSS score formula was constructed as exp (1.4 × heart disease + 0.9 × liver disease + 0.9 × diabetes + 0.9 × sepsis + 0.6 × alanine aminotransferase ≥42 IU/L + 0.6 × hemoglobin ≤9 g/dL + 0.4 × serum ferritin ≥1850 ng/mL). TIPSS score thresholds of greatest differentiation were assigned as <2.0 (low-risk), 2.0 to <5.0 (intermediate-risk), and ≥5.0 (high-risk). The TIPSS score was a good predictor for the outcome of death in the validation dataset (AUC 0.722, 95%CI 0.641-0.804) and survival was significantly different between patients in the three risk categories (P < 0.001). Compared to low-risk patients, the hazard ratio for death was 2.778 (95%CI 1.335-5.780) in patients with intermediate-risk and 6.431 (95%CI 3.151-13.128) in patients with high-risk. This study provides a novel tool to support mortality risk categorization for patients with ß-thalassemia that could help management and research decisions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Talasemia / Talasemia beta / Derivación Portosistémica Intrahepática Transyugular Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cells Mol Dis Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Talasemia / Talasemia beta / Derivación Portosistémica Intrahepática Transyugular Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cells Mol Dis Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia